CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
The SYNvia project explores the principles of synthetic lethality and viability in DNA damage response mechanisms to develop new cancer therapies. It focuses on breast and prostate cancers, aiming to personalize treatment strategies and improve patient outcomes.
The key objective of this Marie Curie project is to explore the ‘synthetic lethality’ and ‘synthetic viability’ principles applied to DNA damage response (DDR) mechanisms and help derive new therapies and/or biomarkers for personalized treatment of breast and prostate cancer.
As these tumors are major causes of mortality and morbidity in Europe, and this multifaceted project in an outstanding host environment provide unique opportunities for training, this ‘SYNvia’ proposal directly addresses th…
KRAEFTENS BEKAEMPELSE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
